Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 8/2018

01-08-2018 | Letter

Reply to “At what price decreased mortality risk?”

Authors: K.L. Ong, D.P. Beall, M. Frohbergh, E. Lau, J.A. Hirsch

Published in: Osteoporosis International | Issue 8/2018

Login to get access

Excerpt

Rodriguez and Ebeling provide thoughtful comments regarding our study [1]. They agreed with the well-documented fact that fewer augmentations were done following publication of the 2009 “sham” trials [2]. Moreover, they acknowledged the resultant elevated mortality risk in VCF patients from 2010 to 2014. We agree with their statement that it is “alarming though that the reductions in mortality risks in the post-2009 (sham trials) era were attenuated.” …
Literature
1.
Ong KL, Beall DP, Frohbergh M, Lau E, Hirsch JA (2018) Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? Osteoporos Int 29(2):375–383CrossRefPubMed
2.
Hirsch JA, Chandra RV, Pampati V, Barr JD, Brook AL, Manchikanti L (2016) Analysis of vertebral augmentation practice patterns: a 2016 update. J Neurointerv Surg 8:1299–1304CrossRefPubMed
3.
Edidin AA, Ong KL, Lau E, Schmier JK, Kemner JE, Kurtz SM (2012) Cost-effectiveness analysis of treatments for vertebral compression fractures. Appl Health Econ Health Policy 10(4):273–284CrossRefPubMed
4.
Ong KL, Lau E, Kemner JE, Kurtz SM (2013) Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading? Osteoporos Int 24(4):1437–1445CrossRefPubMed
5.
Lau E, Ong K, Kurtz S, Schmier J, Edidin A (2008) Mortality following the diagnosis of a vertebral compression fracture in the Medicare population. J Bone Joint Surg Am 90(7):1479–1486CrossRefPubMed
6.
Chen AT, Cohen DB, Skolasky RL (2013) Impact of nonoperative treatment, vertebroplasty, and kyphoplasty on survival and morbidity after vertebral compression fracture in the medicare population. J Bone Joint Surg Am 95(19):1729–1736CrossRefPubMed
7.
Edidin AA, Ong KL, Lau E, Kurtz SM (2011) Mortality risk for operated and nonoperated vertebral fracture patients in the medicare population. J Bone Miner Res 26(7):1617–1626CrossRefPubMed
8.
Edidin AA, Ong KL, Lau E, Kurtz SM (2015) Morbidity and mortality after vertebral fractures: comparison of vertebral augmentation and nonoperative Management in the Medicare Population. Spine (Phila Pa 1976) 40(15):1228–1241CrossRef
9.
Lange A, Kasperk C, Alvares L, Sauermann S, Braun S (2014) Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data. Spine (Phila Pa 1976) 39(4):318–326CrossRef
10.
McCullough BJ, Comstock BA, Deyo RA, Kreuter W, Jarvik JG (2013) Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Intern Med 173(16):1514–1521CrossRefPubMedPubMedCentral
Metadata
Title
Reply to “At what price decreased mortality risk?”
Authors
K.L. Ong
D.P. Beall
M. Frohbergh
E. Lau
J.A. Hirsch
Publication date
01-08-2018
Publisher
Springer London
Published in
Osteoporosis International / Issue 8/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4551-4

Other articles of this Issue 8/2018

Osteoporosis International 8/2018 Go to the issue

Original Article

Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong

Original Article

Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia—not atypical at all

Original Article

Constitutive melanin density is associated with higher 25-hydroxyvitamin D and potentially total body BMD in older Caucasian adults via increased sun tolerance and exposure

Original Article

Whole egg consumption and cortical bone in healthy children

Original Article

Rush Fracture Liaison Service for capturing “missed opportunities” to treat osteoporosis in patients with fragility fractures

Original Article

Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells